Crossmark

Assessment of Clinical Meaningfulness of Endpoints in the Generation Program by the Insights to Model Alzheimer's Progression in Real Life (iMAP) Study

Crossref DOI link: https://doi.org/10.14283/jpad.2018.49

Published Print: 2019-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Graf, Ana

Risson, V.

Gustavsson, A.

Bezlyak, V.

Caputo, A.

Tariot, P.N.

Langbaum, J.B.

Lopez Lopez, C.

Viglietta, V.
License Information

Text and Data Mining valid from 2019-04-01

Text and Data Mining valid from 2019-04-01

Version of Record valid from 2024-09-25
More Information

This article is maintained by: Elsevier

Article Title: Assessment of Clinical Meaningfulness of Endpoints in the Generation Program by the Insights to Model Alzheimer's Progression in Real Life (iMAP) Study

Journal Title: The Journal of Prevention of Alzheimer's Disease

CrossRef DOI link to publisher maintained version: https://doi.org/10.14283/jpad.2018.49

Content Type: article

Copyright: Copyright © 2018 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS

Document is current

Any future updates will be listed below